This study establishes a mechanistic framework that integrates biochemical and biomechanical risk factors of POAG and highlights the pivotal role of TRPV4, a polymodal Ca2+-permeable channel, as a key regulator of TM contractility and ocular hypertension. This evidence concerns the gene TRPV4 and ocular hypertension.